Indole Derivatives for 5-HT2A Activation and Sustained Therapy

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current treatments for mental health disorders and neurological diseases, such as depression, anxiety, and psychosis, are inadequate in providing sustained relief and are limited by high morbidity and limited efficacy of conventional pharmacological and psychosocial interventions.

Innovation Solution

Development of indole derivatives that activate serotonin receptors, particularly 5-HT2A receptors, to induce therapeutic effects through both biochemical and psycho-spiritual experiences, including the use of microdosing paradigms for chronic conditions and hallucinogenic doses for acute treatment.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Duration of action of moving object

If conventional pharmacological treatments are used for mental health disorders, then initial symptom relief may be achieved, but sustained relief is inadequate and efficacy is limited

Engineering Contradiction:
Improveduration of therapeutic effectVSAvoidefficacy of treatment
Core Design Contradiction:
Duration of action of moving objectVSReliability

Solution Approach 1:

The patent modifies the chemical structure of serotonergic compounds by changing molecular parameters (introducing indole core structure with specific substituents at positions 2, 3, or 4) to enhance receptor affinity and signaling efficacy, thereby improving both duration and reliability of therapeutic effect

Inventive Principle:
Principle #35Parameter changes

2Reliability

If traditional psychedelics are used to treat mental health disorders, then rapid and sustained therapeutic effects are achieved, but safety concerns and adverse reactions occur

Engineering Contradiction:
Improvetherapeutic efficacyVSAvoidsafety profile
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent introduces specific local chemical modifications at defined positions (2, 3, or 4) of the indole ring system, allowing precise control over receptor binding characteristics and signaling pathways to achieve therapeutic effects while minimizing harmful reactions

Inventive Principle:
Principle #3Local quality

Solution Approach 2:

The compounds combine multiple functional features in a single molecular structure: the indole core provides serotonergic activity, while specific substituents at different positions contribute to pharmacokinetic properties, receptor selectivity, and safety profile

Inventive Principle:
Principle #40Composite materials

3Duration of action of stationary object

If repeated administration of psychedelics is given, then therapeutic effects are maintained, but rapid tolerance development occurs

Engineering Contradiction:
Improveduration of therapeutic effectVSAvoidresponse to treatment
Core Design Contradiction:
Duration of action of stationary objectVSReliability

Solution Approach 1:

The patent creates a series of related compounds with systematic variations at specific positions of the indole structure, allowing differentiation of pharmacological properties to reduce tolerance through structural diversity while maintaining therapeutic mechanism

Inventive Principle:
Principle #1Segmentation

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The indole derivatives provide rapid and sustained antidepressant, anxiolytic, and neuroprotective effects, improving mood and cognitive function, and reducing symptoms of psychosis and neurodegeneration, with a safer profile than traditional psychedelics.

Implementation Method 1

indole derivatives that activate serotonin receptors, particularly 5-HT2A receptors, to induce therapeutic effects

Methodology Applied
Scientific EffectReceptor binding and activation:

Data Source

PatentUS20250257034A1Indole derivatives as serotonergic agents useful for the treatment of disorders related thereto
Publication Date: 2025.08.14 MINDSET PHARMA INC
  • US20250257034A1 patent drawing
  • US20250257034A1 patent drawing
  • US20250257034A1 patent drawing

AI summary

The present disclosure relates to indole derivatives of general Formula (I), to processes for their preparation, to compositions including them and to their use in activation of a serotonin receptors in a cell, as well as to treating diseases, disorders, or conditions by activation of a serotonin receptors in a cell. The diseases, disorders, or conditions include, for example, psychosis, mental illnesses, and central nervous system (CNS) disorders.